PRED in Medical Technology

Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

...endogenous anterior uveitis based partially on a head to head comparison to pred Forte(R). The application was accepted in February 2009 by the agency and i... Posterboard Number: A351 - Program Number: 1461 Durezol Compared to pred Forte (R) in the Treatment of Endogenous Anterior Uveitis Session Da...

Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented

...ic emulsion) 0.05% dosed four times daily (QID) to pred Forte(R)* (prednisolone acetate ophthalmic suspens...na Care, in his presentation, "Durezol Compared to pred Forte in the Treatment of Endogenous Anterior Uvei...tudy, Durezol administered QID was as effective as pred Forte dosed eight times a day in treating uveitis....

Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)

...ic emulsion) 0.05% dosed four times daily (QID) to pred Forte(R) (prednisolone acetate ophthalmic suspensi... the US Food and Drug Administration in June 2008. pred Forte(R) is the registered trademark of Allergan, ...mpared the efficacy and safety of Durezol QID with pred Forte eight times a day. Treatment for both study ...